American Financial Group Inc Abb Vie Inc. Transaction History

American Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $1.72 Million - $2.02 Million	-20,000 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$73.37 - $98.18 $11 Million - $14.7 Million	-150,000 Reduced 88.24%	20,000 $1.96 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $8.19 Million - $9.84 Million	130,000 Added 325.0%	170,000 $12.9 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $2.63 Million - $3.36 Million	40,000 New	40,000 $2.91 Million

3,848

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of American Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on American Financial Group Inc with notifications on news.